DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 3 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,961 | +133.3% | 311,400 | +158.2% | 0.01% | +250.0% |
| Q2 2023 | $1,698 | -52.5% | 120,600 | -47.9% | 0.00% | -60.0% |
| Q1 2023 | $3,574 | +140.3% | 231,318 | +155.0% | 0.01% | +150.0% |
| Q4 2022 | $1,487 | -99.9% | 90,700 | +2.0% | 0.00% | +100.0% |
| Q2 2022 | $1,169,000 | -1.2% | 88,900 | +155.5% | 0.00% | -50.0% |
| Q3 2021 | $1,183,000 | -93.1% | 34,800 | -91.7% | 0.00% | -88.2% |
| Q1 2020 | $17,234,000 | +29.0% | 418,600 | +95.1% | 0.02% | +70.0% |
| Q4 2019 | $13,357,000 | +173.9% | 214,600 | +49.3% | 0.01% | +150.0% |
| Q3 2019 | $4,877,000 | – | 143,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,086,723 | $85,910,000 | 25.70% |
| SV Health Investors, LLC | 449,951 | $18,525,000 | 15.54% |
| Redmile Group, LLC | 5,116,263 | $210,637,000 | 5.90% |
| Eversept Partners, LP | 414,081 | $17,047,715 | 4.24% |
| Sunesis Advisors, LLC | 96,299 | $3,965,000 | 3.99% |
| Avoro Capital Advisors LLC | 2,000,000 | $82,340,000 | 2.78% |
| Opaleye Management Inc. | 222,000 | $9,140,000 | 2.42% |
| SECTORAL ASSET MANAGEMENT INC | 204,059 | $8,401,000 | 1.61% |
| Artal Group S.A. | 800,000 | $32,936,000 | 1.39% |
| Atika Capital Management LLC | 141,000 | $5,805,000 | 1.11% |